| Jacquelin L Lyle, | |
|
1735 Melrose Ave Unit 53, Chula Vista, CA 91911-6572 | |
| (619) 426-0926 | |
| Not Available |
| Full Name | Jacquelin L Lyle |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1735 Melrose Ave Unit 53, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003091760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacquelin L Lyle, 1735 Melrose Ave Unit 53, Chula Vista, CA 91911-6572 Ph: (619) 426-0926 | Jacquelin L Lyle, 1735 Melrose Ave Unit 53, Chula Vista, CA 91911-6572 Ph: (619) 426-0926 |
News Archive
Children born with cleft lip and cleft palate (CLP) commonly undergo multiple surgical procedures between infancy and adolescence. By the time they are teens, patients with CLP with more total surgeries do not have increased psychosocial problems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed psychiatrists say that the decrease in severity of manic symptoms is the attribute that most influences their prescribing decisions in bipolar mania. Clinical data and the opinions of interviewed thought leaders indicate that Eli Lilly's Zyprexa (olanzapine) has advantages in this attribute over AstraZeneca/Astellas's Seroquel (quetiapine), the sales-leading agent in the bipolar disorder drug market.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer's disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland.
› Verified 9 days ago
Stephanie Velbis, Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 691-397-6931 | |
Michael Lozano, B.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 264 Landis Ave Ste 200, Chula Vista, CA 91910 Phone: 619-997-6851 | |
Raul Franco, CADC-II Counselor Medicare: Not Enrolled in Medicare Practice Location: 73 N 2nd Ave Ste B, Chula Vista, CA 91910 Phone: 619-426-4801 Fax: 619-426-0034 | |
Jamie Rhine, Counselor Medicare: Not Enrolled in Medicare Practice Location: 855 3rd Ave Ste 1110, Chula Vista, CA 91911 Phone: 619-934-5770 | |
Cordelia Woodhouse, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1105 Broadway, Suite 207, Chula Vista, CA 91911 Phone: 619-425-5609 Fax: 619-425-8349 | |
Alejandra Vargas, Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-397-6931 |